Good Distribution Practice (GDP) road logistics refers to the application of GDP standards to the overland transportation of pharmaceutical and healthcare products. As one of the most commonly used modes of transport within regional supply chains, road logistics plays a critical role in maintaining the integrity, quality, and compliance of medicinal products from manufacturing sites and central warehouses to hospitals, pharmacies, wholesalers, and clinical trial sites.

Unlike other industries, the pharmaceutical sector is subject to strict regulatory oversight to ensure that products are transported under conditions that preserve their safety and efficacy. GDP, as defined by entities such as the European Medicines Agency (EMA) and World Health Organization (WHO), sets forth a series of guidelines covering the transportation, handling, documentation, and personnel involved in the distribution of medicines. In the context of road logistics, this means implementing rigorous controls over temperature, cleanliness, traceability, and risk mitigation — even over short distances.

Pharmaceutical products may be sensitive to temperature deviations, vibrations, humidity, light exposure, or physical damage, all of which can occur during overland transport. As a result, GDP-compliant road logistics must rely on validated vehicles (such as temperature-controlled vans or trailers), calibrated temperature monitoring devices, qualified drivers, and strict operational procedures to ensure end-to-end compliance.